Literature DB >> 17264327

Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques.

C Pandya1, R C Brunken, P Tchou, P Schoenhagen, D A Culver.   

Abstract

Diagnosis of cardiac involvement in sarcoidosis is challenging and usually relies on a combination of clinical findings and imaging abnormalities. The case of a 53-yr-old female is described who presented with ventricular tachycardia and suspected angiosarcoma involving the right atrium and superior vena cava. A combination of magnetic resonance imaging and (18)F-2-fluoro-2-deoxyglucose-positron emission tomography were essential to the diagnosis of cardiac sarcoidosis. Reversibility of the disease was predicted more clearly by (18)F-2-fluoro-2-deoxyglucose-positron emission tomography than by magnetic resonance imaging, and clinical activity was predicted by persistent hypermetabolism on serial (18)F-2-fluoro-2-deoxyglucose-positron emission tomography.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264327     DOI: 10.1183/09031936.00076406

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

Review 1.  Cardiac sarcoidosis.

Authors:  Matthew M Zipse; William H Sauer
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

Review 2.  18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

Authors:  Hicham Skali; Allison R Schulman; Sharmila Dorbala
Journal:  Curr Cardiol Rep       Date:  2013-04       Impact factor: 2.931

Review 3.  Update on Treatment in Cardiac Sarcoidosis.

Authors:  Laura Young; Brett W Sperry; Rory Hachamovitch
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-06

4.  The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis.

Authors:  Pei-Ing Lee; Gang Cheng; Abass Alavi
Journal:  J Nucl Cardiol       Date:  2016-11-03       Impact factor: 5.952

Review 5.  Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disorders.

Authors:  Sandip Basu; Babak Saboury; Tom Werner; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

Review 6.  ¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.

Authors:  Hiroshi Ohira; Ichizo Tsujino; Keiichiro Yoshinaga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236

Review 7.  The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis.

Authors:  B A Mc Ardle; E Leung; H Ohira; M S Cocker; R A deKemp; J DaSilva; D Birnie; R S Beanlands; P B Nery
Journal:  J Nucl Cardiol       Date:  2013-01-04       Impact factor: 5.952

Review 8.  Idiopathic giant cell myocarditis and cardiac sarcoidosis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

9.  Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis.

Authors:  Michael Soussan; Pierre-Yves Brillet; Hilario Nunes; Gabriel Pop; Matthieu-John Ouvrier; Nicolas Naggara; Dominique Valeyre; Pierre Weinmann
Journal:  J Nucl Cardiol       Date:  2012-11-28       Impact factor: 5.952

10.  Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.

Authors:  Hiroshi Ohira; Ichizo Tsujino; Shinji Ishimaru; Noriko Oyama; Toshiki Takei; Eriko Tsukamoto; Masatake Miura; Shinji Sakaue; Nagara Tamaki; Masaharu Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-15       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.